Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025-02 · 398 (2) · 2015-2026
DOI: 10.1007/s00210-024-03417-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 02.09.2024. Verfasst von Vinay C Sangamesh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nitte University Centre for Science Education and Research, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. Hauptthemen laut MEDLINE: Hydroxychloroquine, ErbB Receptors, Annexin A2, Pulmonary Fibrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nitte University Centre for Science Education and Research, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India.
- Central Research Laboratory, KS. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India.
- Central Research Laboratory, KS. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. praveenkumarshetty@nitte.edu.in.
- Department of Biochemistry, K.S. Hegde Medical Academy, Nitte (Deemed to Be University), Deralakatte, Mangalore, 575018, Karnataka, India. praveenkumarshetty@nitte.edu.in.
Zitieren
APA
Sangamesh, V. C., Alagundagi, D. B., Jayaswamy, P. K., Kuriakose, N., & Shetty, P. (2025). Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(2), 2015-2026. https://doi.org/10.1007/s00210-024-03417-9
Vancouver
Sangamesh VC, Alagundagi DB, Jayaswamy PK, Kuriakose N, Shetty P. Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025;398(2):2015-2026. doi:10.1007/s00210-024-03417-9
BibTeX
@article{Sangamesh2025,
author = {Sangamesh, Vinay C and Alagundagi, Dhananjay B and Jayaswamy, Pavan K and Kuriakose, Nithin and Shetty, Praveenkumar},
title = {Targeting AnxA2-EGFR signaling: hydroxychloroquine as a therapeutic strategy for bleomycin-induced pulmonary fibrosis},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2025},
volume = {398},
number = {2},
pages = {2015--2026},
doi = {10.1007/s00210-024-03417-9}
}
EUVIMED